SECsense Logo

Lipella Pharmaceuticals Inc. 8-K Report: Key Updates & Insights

$LIPO
Form 8-K
Filed on: 2024-12-20
Source
Lipella Pharmaceuticals Inc. 8-K Report: Key Updates & Insights

Based on the provided XML section of the financial report, here are the key pieces of information extracted:

  1. Entity Identification:
  • Company Name: Lipella Pharmaceuticals Inc.
  • CIK (Central Index Key): 0001347242
  • SEC File Number: 005-93847
  • EIN (Employer Identification Number): 20-2388040
  1. Reporting Date:
  • Filing Date: December 20, 2024
  • Report Type: 8-K (current report to disclose unscheduled material events or corporate changes)
  1. Address:
  • Location: 7800 Susquehanna St. Suite 505, Pittsburgh, PA 15208
  • Phone Number: (412) 894-1853
  1. Stock Information:
  • Type of Stock: Common Stock
  • Par Value: $0.0001 per share
  • Ticker Symbol: LIPO
  • Exchange: NASDAQ
  1. Units of Measure:
  • The financial data is reported in USD (United States Dollars) and shares, indicating that the report may contain information on stock performance or capital changes.

Insights:

  • The report indicates that Lipella Pharmaceuticals Inc. is a publicly traded company on NASDAQ under the ticker LIPO, which may be significant for investors monitoring pharmaceutical stocks.
  • The 8-K filing suggests that there may be material information disclosed that could impact the company’s stock price or investor decisions.
  • The specifics of the report (e.g., financial performance, events, or changes) are not included in this XML snippet but would be critical for a full analysis.